Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Adenocarcinoma of Lung × Base Sequence × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Leukemia 7 Sarcoma 5 Neoplasms 4 Colorectal Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Melanoma 2 Lymphoma, Large B-Cell, Diffuse 2 Leukemia, Myelomonocytic, Acute 2 Leukemia, Myeloid, Acute 2 Leukemia, Monocytic, Acute 2 Leukemia, Megakaryoblastic, Acute 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia, Erythroblastic, Acute 2 Head and Neck Neoplasms 2 Congenital Abnormalities 2 Cholangiocarcinoma 2 Breast Neoplasms 2 Biliary Tract Neoplasms 2 Waldenstrom Macroglobulinemia 1 Unspecified Adult Solid Tumor, Protocol Specific 1 Triple Negative Breast Neoplasms 1 Toxoplasmosis 1 Thrombocytosis 1 Testicular Neoplasms 1 Testicular Germ Cell Tumor 1 Recurrence 1 Rectal Neoplasms 1 Radiation Injuries 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1

Interventions

Carboplatin 57 Paclitaxel 38 Radiotherapy 36 Bevacizumab 36 Pemetrexed 35 Cisplatin 35 Gemcitabine 22 Docetaxel 22 Erlotinib Hydrochloride 19 Gefitinib 15 pembrolizumab 12 Taxes 9 Cetuximab 9 Magnetic Resonance Spectroscopy 8 Nivolumab 7 Vinorelbine 6 Radiotherapy, Conformal 6 Radiosurgery 6 Platinum 6 capmatinib 5 Surgical Procedures, Operative 5 Radiation 5 Neoadjuvant Therapy 5 Mastectomy, Segmental 5 Cyclophosphamide 5 Biopsy 5 ceritinib 4 aflutinib 4 Specimen Handling 4 Sorafenib 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02843711 2016-07-26

LUNG-EST

Hospices Civils de Lyon

Adenocarcinoma of Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡